Concepedia

Publication | Open Access

Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer

33

Citations

50

References

2020

Year

Abstract

We demonstrate that afatinib combined with dasatinib has potential clinical activity in TNBC but warrants further preclinical investigation.

References

YearCitations

Page 1